-
1
-
-
0000003923
-
Retrecissement cardiaque, sous-aortique
-
Liouville H. Retrecissement cardiaque, sous-aortique. Gazette Medicale de Paris 1869;24:161-5.
-
(1869)
Gazette Medicale de Paris
, vol.24
, pp. 161-165
-
-
Liouville, H.1
-
2
-
-
2442565025
-
Ueber linkseitige muskulose conusstenosen
-
Schmincke A. Ueber linkseitige muskulose conusstenosen. Dtsch Med Wochenschr 1907;33:2082-3.
-
(1907)
Dtsch Med Wochenschr
, vol.33
, pp. 2082-2083
-
-
Schmincke, A.1
-
3
-
-
0000861028
-
Hemodynamic alterations in idiopathic hypertrophic subaortic stenosis induced by sympathomimetic drugs
-
Braunwald E, Ebert PA. Hemodynamic alterations in idiopathic hypertrophic subaortic stenosis induced by sympathomimetic drugs. Am J Cardiol 1962;10:489-95.
-
(1962)
Am J Cardiol
, vol.10
, pp. 489-495
-
-
Braunwald, E.1
Ebert, P.A.2
-
4
-
-
0002206328
-
Idiopathic hypertrophic subaortic stenosis. I. A description of the disease based upon an analysis of 64 patients
-
Braunwald E, Lambrew CT, Rockoff SD, Ross J Jr, Morrow AG. Idiopathic hypertrophic subaortic stenosis. I. A description of the disease based upon an analysis of 64 patients. Circulation 1964;30:Suppl 4:3-119.
-
(1964)
Circulation
, vol.30
, Issue.SUPPL. 4
, pp. 3-119
-
-
Braunwald, E.1
Lambrew, C.T.2
Rockoff, S.D.3
Ross Jr, J.4
Morrow, A.G.5
-
5
-
-
0005261851
-
Idiopathic hypertrophic subaortic stenosis. II. Operative treatment and the results of pre- and postoperative hemodynamic evaluations
-
Morrow AG, Lambrew CT, Braunwald E. Idiopathic hypertrophic subaortic stenosis. II. Operative treatment and the results of pre- and postoperative hemodynamic evaluations. Circulation 1964;30:Suppl 4:120-51.
-
(1964)
Circulation
, vol.30
, Issue.SUPPL. 4
, pp. 120-151
-
-
Morrow, A.G.1
Lambrew, C.T.2
Braunwald, E.3
-
6
-
-
0015583171
-
Asymmetric septal hypertrophy. Echocardiographic identification of the pathognomonic anatomic abnormality of IHSS
-
Henry WL, Clark CE, Epstein SE. Asymmetric septal hypertrophy. Echocardiographic identification of the pathognomonic anatomic abnormality of IHSS. Circulation 1973; 47(2):225-33.
-
(1973)
Circulation
, vol.47
, Issue.2
, pp. 225-233
-
-
Henry, W.L.1
Clark, C.E.2
Epstein, S.E.3
-
7
-
-
0016791550
-
Hypertrophic obstructive cardiomyopathy. Assessment by echocardiographic and Doppler ultrasound techniques
-
Boughner DR, Schuld RL, Persaud JA. Hypertrophic obstructive cardiomyopathy. Assessment by echocardiographic and Doppler ultrasound techniques. Br Heart J 1975;37(9):917-23.
-
(1975)
Br Heart J
, vol.37
, Issue.9
, pp. 917-923
-
-
Boughner, D.R.1
Schuld, R.L.2
Persaud, J.A.3
-
8
-
-
0015061513
-
Diagnosis of hypertrophic subaortic stenosis with a Doppler velocity flow detector
-
Joyner CR, Harrison FS Jr, Gruber JW. Diagnosis of hypertrophic subaortic stenosis with a Doppler velocity flow detector. Ann Intern Med 1971;74(5):692-6.
-
(1971)
Ann Intern Med
, vol.74
, Issue.5
, pp. 692-696
-
-
Joyner, C.R.1
Harrison Jr, F.S.2
Gruber, J.W.3
-
9
-
-
0021833046
-
Dynamic subaortic obstruction in hypertrophic cardiomyopathy: Analysis by pulsed Doppler echocardiography
-
Maron BJ, Gottdiener JS, Arce J, Rosing DR, Wesley YE, Epstein SE. Dynamic subaortic obstruction in hypertrophic cardiomyopathy: analysis by pulsed Doppler echocardiography. J Am Coll Cardiol 1985;6(1):1-18.
-
(1985)
J Am Coll Cardiol
, vol.6
, Issue.1
, pp. 1-18
-
-
Maron, B.J.1
Gottdiener, J.S.2
Arce, J.3
Rosing, D.R.4
Wesley, Y.E.5
Epstein, S.E.6
-
10
-
-
0022606691
-
Left ventricular filling in hypertrophic cardiomyopathy: A pulsed Doppler echocardiographic study
-
Takenaka K, Dabestani A, Gardin JM, Russell D, Clark S, Allfie A, Henry WL. Left ventricular filling in hypertrophic cardiomyopathy: a pulsed Doppler echocardiographic study. J Am Coll Cardiol 1986;7(6):1263-71.
-
(1986)
J Am Coll Cardiol
, vol.7
, Issue.6
, pp. 1263-1271
-
-
Takenaka, K.1
Dabestani, A.2
Gardin, J.M.3
Russell, D.4
Clark, S.5
Allfie, A.6
Henry, W.L.7
-
11
-
-
0041663643
-
Tissue Doppler imaging predicts the development of hypertrophic cardiomyopathy in subjects with subclinical disease
-
Nagueh SF, McFalls J, Meyer D, Hill R, Zoghbi WA, Tam JW, et al. Tissue Doppler imaging predicts the development of hypertrophic cardiomyopathy in subjects with subclinical disease. Circulation 2003;108(4):395-8.
-
(2003)
Circulation
, vol.108
, Issue.4
, pp. 395-398
-
-
Nagueh, S.F.1
McFalls, J.2
Meyer, D.3
Hill, R.4
Zoghbi, W.A.5
Tam, J.W.6
-
12
-
-
0035838393
-
Tissue Doppler imaging consistently detects myocardial abnormalities in patients with hypertrophic cardiomyopathy and provides a novel means for an early diagnosis before and independently of hypertrophy
-
Nagueh SF, Bachinski LL, Meyer D, Hill R, Zoghbi WA, Tam JW, et al. Tissue Doppler imaging consistently detects myocardial abnormalities in patients with hypertrophic cardiomyopathy and provides a novel means for an early diagnosis before and independently of hypertrophy. Circulation 2001;104(2): 128-30.
-
(2001)
Circulation
, vol.104
, Issue.2
, pp. 128-130
-
-
Nagueh, S.F.1
Bachinski, L.L.2
Meyer, D.3
Hill, R.4
Zoghbi, W.A.5
Tam, J.W.6
-
13
-
-
0025040392
-
A molecular basis for familial hypertrophic cardiomyopathy: A beta cardiac myosin heavy chain gene missense mutation
-
Geisterfer-Lowrance AA, Kass S, Tanigawa G, Vosberg HP, McKenna W, Seidman CE, Seidman JG. A molecular basis for familial hypertrophic cardiomyopathy: a beta cardiac myosin heavy chain gene missense mutation. Cell 1990;62(5):999-1006.
-
(1990)
Cell
, vol.62
, Issue.5
, pp. 999-1006
-
-
Geisterfer-Lowrance, A.A.1
Kass, S.2
Tanigawa, G.3
Vosberg, H.P.4
McKenna, W.5
Seidman, C.E.6
Seidman, J.G.7
-
14
-
-
41749094096
-
Genetic determinants of cardiac hypertrophy
-
Marian AJ. Genetic determinants of cardiac hypertrophy. Curr Opin Cardiol 2008;23(3):199-205.
-
(2008)
Curr Opin Cardiol
, vol.23
, Issue.3
, pp. 199-205
-
-
Marian, A.J.1
-
15
-
-
0029043605
-
Non-surgical myocardial reduction for hypertrophic obstructive cardiomyopathy
-
Sigwart U. Non-surgical myocardial reduction for hypertrophic obstructive cardiomyopathy. Lancet 1995;346(8969): 211-4.
-
(1995)
Lancet
, vol.346
, Issue.8969
, pp. 211-214
-
-
Sigwart, U.1
-
16
-
-
0035289741
-
Current status of alcohol septal ablation for patients with hypertrophic cardiomyopathy
-
Seggewiss H. Current status of alcohol septal ablation for patients with hypertrophic cardiomyopathy. Curr Cardiol Rep 2001;3(2):160-6.
-
(2001)
Curr Cardiol Rep
, vol.3
, Issue.2
, pp. 160-166
-
-
Seggewiss, H.1
-
17
-
-
10644280153
-
Alcohol septal ablation versus surgical septal myectomy: Comparison of effects on atrioventricular conduction tissue
-
Talreja DR, Nishimura RA, Edwards WD, Valeti US, Ommen SR, Tajik AJ, et al. Alcohol septal ablation versus surgical septal myectomy: comparison of effects on atrioventricular conduction tissue. J Am Coll Cardiol 2004;44(12):2329-32.
-
(2004)
J Am Coll Cardiol
, vol.44
, Issue.12
, pp. 2329-2332
-
-
Talreja, D.R.1
Nishimura, R.A.2
Edwards, W.D.3
Valeti, U.S.4
Ommen, S.R.5
Tajik, A.J.6
-
18
-
-
47649084105
-
Outcome of alcohol septal ablation for obstructive hypertrophic cardiomyopathy
-
Sorajja P, Valeti U, Nishimura RA, Ommen SR, Rihal CS, Gersh BJ, et al. Outcome of alcohol septal ablation for obstructive hypertrophic cardiomyopathy. Circulation 2008;118(2): 131-9.
-
(2008)
Circulation
, vol.118
, Issue.2
, pp. 131-139
-
-
Sorajja, P.1
Valeti, U.2
Nishimura, R.A.3
Ommen, S.R.4
Rihal, C.S.5
Gersh, B.J.6
-
19
-
-
62649113485
-
Sudden deaths in young competitive athletes: Analysis of 1866 deaths in the United States, 1980-2006
-
Maron BJ, Doerer JJ, Haas TS, Tierney DM, Mueller FO. Sudden deaths in young competitive athletes: analysis of 1866 deaths in the United States, 1980-2006. Circulation 2009;119 (8):1085-92.
-
(2009)
Circulation
, vol.119
, Issue.8
, pp. 1085-1092
-
-
Maron, B.J.1
Doerer, J.J.2
Haas, T.S.3
Tierney, D.M.4
Mueller, F.O.5
-
20
-
-
85136377980
-
-
Maron BJ, Shirani J, Poliac LC, Mathenge R, Roberts WC, Mueller FO. Sudden death in young competitive athletes. Clinical, demographic, and pathological profiles. JAMA 1996; 276(3):199-204.
-
Maron BJ, Shirani J, Poliac LC, Mathenge R, Roberts WC, Mueller FO. Sudden death in young competitive athletes. Clinical, demographic, and pathological profiles. JAMA 1996; 276(3):199-204.
-
-
-
-
21
-
-
34547188258
-
-
Maron BJ, Spirito P, Shen WK, Haas TS, Formisano F, Link MS, et al. Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy [published erratum appears in JAMA 2007;298(13):1516]. JAMA 2007;298(4):405-12.
-
Maron BJ, Spirito P, Shen WK, Haas TS, Formisano F, Link MS, et al. Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy [published erratum appears in JAMA 2007;298(13):1516]. JAMA 2007;298(4):405-12.
-
-
-
-
22
-
-
0034628532
-
Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy
-
Maron BJ, Shen WK, Link MS, Epstein AE, Almquist AK, Daubert JP, et al. Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy. N Engl J Med 2000;342(6): 365-73.
-
(2000)
N Engl J Med
, vol.342
, Issue.6
, pp. 365-373
-
-
Maron, B.J.1
Shen, W.K.2
Link, M.S.3
Epstein, A.E.4
Almquist, A.K.5
Daubert, J.P.6
-
23
-
-
64549096033
-
Resolution of established cardiac hypertrophy and fibrosis and prevention of systolic dysfunction in a transgenic rabbit model of human cardiomyopathy through thiol-sensitive mechanisms
-
Lombardi R, Rodriguez G, Chen SN, Ripplinger CM, Li W, Chen J, et al. Resolution of established cardiac hypertrophy and fibrosis and prevention of systolic dysfunction in a transgenic rabbit model of human cardiomyopathy through thiol-sensitive mechanisms. Circulation 2009;119(10):1398-407.
-
(2009)
Circulation
, vol.119
, Issue.10
, pp. 1398-1407
-
-
Lombardi, R.1
Rodriguez, G.2
Chen, S.N.3
Ripplinger, C.M.4
Li, W.5
Chen, J.6
-
24
-
-
32644446037
-
Antifibrotic effects of antioxidant N-acetylcysteine in a mouse model of human hypertrophic cardiomyopathy mutation
-
Marian AJ, Senthil V, Chen SN, Lombardi R. Antifibrotic effects of antioxidant N-acetylcysteine in a mouse model of human hypertrophic cardiomyopathy mutation. J Am Coll Cardiol 2006;47(4):827-34.
-
(2006)
J Am Coll Cardiol
, vol.47
, Issue.4
, pp. 827-834
-
-
Marian, A.J.1
Senthil, V.2
Chen, S.N.3
Lombardi, R.4
-
25
-
-
23344440434
-
Prevention of cardiac hypertrophy by atorvastatin in a transgenic rabbit model of human hypertrophic cardiomyopathy
-
Senthil V, Chen SN, Tsybouleva N, Halder T, Nagueh SF, Willerson JT, et al. Prevention of cardiac hypertrophy by atorvastatin in a transgenic rabbit model of human hypertrophic cardiomyopathy. Circ Res 2005;97(3):285-92.
-
(2005)
Circ Res
, vol.97
, Issue.3
, pp. 285-292
-
-
Senthil, V.1
Chen, S.N.2
Tsybouleva, N.3
Halder, T.4
Nagueh, S.F.5
Willerson, J.T.6
-
26
-
-
0035902491
-
Simvastatin induces regression of cardiac hypertrophy and fibrosis and improves cardiac function in a transgenic rabbit model of human hypertrophic cardiomyopathy
-
Patel R, Nagueh SF, Tsybouleva N, Abdellatif M, Lutucuta S, Kopelen HA, et al. Simvastatin induces regression of cardiac hypertrophy and fibrosis and improves cardiac function in a transgenic rabbit model of human hypertrophic cardiomyopathy. Circulation 2001;104(3):317-24.
-
(2001)
Circulation
, vol.104
, Issue.3
, pp. 317-324
-
-
Patel, R.1
Nagueh, S.F.2
Tsybouleva, N.3
Abdellatif, M.4
Lutucuta, S.5
Kopelen, H.A.6
-
27
-
-
0035852766
-
Angiotensin II blockade reverses myocardial fibrosis in a transgenic mouse model of human hypertrophic cardiomyopathy
-
Lim DS, Lutucuta S, Bachireddy P, Youker K, Evans A, Entman M, et al. Angiotensin II blockade reverses myocardial fibrosis in a transgenic mouse model of human hypertrophic cardiomyopathy. Circulation 2001;103(6):789-91.
-
(2001)
Circulation
, vol.103
, Issue.6
, pp. 789-791
-
-
Lim, D.S.1
Lutucuta, S.2
Bachireddy, P.3
Youker, K.4
Evans, A.5
Entman, M.6
-
28
-
-
0029083650
-
Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults
-
Maron BJ, Gardin JM, Flack JM, Gidding SS, Kurosaki TT, Bild DE. Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults. Circulation 1995;92(4):785-9.
-
(1995)
Circulation
, vol.92
, Issue.4
, pp. 785-789
-
-
Maron, B.J.1
Gardin, J.M.2
Flack, J.M.3
Gidding, S.S.4
Kurosaki, T.T.5
Bild, D.E.6
-
29
-
-
0025259149
-
Syncope in hypertrophic cardiomyopathy: Multivariate analysis of prognostic determinants
-
Nienaber CA, Hiller S, Spielmann RP, Geiger M, Kuck KH. Syncope in hypertrophic cardiomyopathy: multivariate analysis of prognostic determinants. J Am Coll Cardiol 1990;15(5):948-55.
-
(1990)
J Am Coll Cardiol
, vol.15
, Issue.5
, pp. 948-955
-
-
Nienaber, C.A.1
Hiller, S.2
Spielmann, R.P.3
Geiger, M.4
Kuck, K.H.5
-
30
-
-
0037454158
-
Hypertrophic cardiomyopathy in a large community-based population: Clinical outcome and identification of risk factors for sudden cardiac death and clinical deterioration
-
Kofflard MJ, Ten Cate FJ, van der Lee C, van Domburg RT. Hypertrophic cardiomyopathy in a large community-based population: clinical outcome and identification of risk factors for sudden cardiac death and clinical deterioration. J Am Coll Cardiol 2003;41(6):987-93.
-
(2003)
J Am Coll Cardiol
, vol.41
, Issue.6
, pp. 987-993
-
-
Kofflard, M.J.1
Ten Cate, F.J.2
van der Lee, C.3
van Domburg, R.T.4
-
31
-
-
0025305889
-
Atrial fibrillation in hypertrophic cardiomyopathy: A longitudinal study
-
Robinson K, Frenneaux MP, Stockins B, Karatasakis G, Poloniecki JD, McKenna WJ. Atrial fibrillation in hypertrophic cardiomyopathy: a longitudinal study. J Am Coll Cardiol 1990;15(6):1279-85.
-
(1990)
J Am Coll Cardiol
, vol.15
, Issue.6
, pp. 1279-1285
-
-
Robinson, K.1
Frenneaux, M.P.2
Stockins, B.3
Karatasakis, G.4
Poloniecki, J.D.5
McKenna, W.J.6
-
32
-
-
0027491649
-
Prognosis in hypertrophic cardiomyopathy observed in a large clinic population
-
Kofflard MJ, Waldstein DJ, Vos J, ten Cate FJ. Prognosis in hypertrophic cardiomyopathy observed in a large clinic population. Am J Cardiol 1993;72(12):939-43.
-
(1993)
Am J Cardiol
, vol.72
, Issue.12
, pp. 939-943
-
-
Kofflard, M.J.1
Waldstein, D.J.2
Vos, J.3
ten Cate, F.J.4
-
33
-
-
0028824221
-
Natural history of hypertrophic cardiomyopathy. A population-based study, 1976 through 1990
-
Cannan CR, Reeder GS, Bailey KR, Melton LJ 3rd, Gersh BJ. Natural history of hypertrophic cardiomyopathy. A population-based study, 1976 through 1990. Circulation 1995;92 (9):2488-95.
-
(1995)
Circulation
, vol.92
, Issue.9
, pp. 2488-2495
-
-
Cannan, C.R.1
Reeder, G.S.2
Bailey, K.R.3
Melton 3rd, L.J.4
Gersh, B.J.5
-
34
-
-
0034660438
-
Magnitude of left ventricular hypertrophy and risk of sudden death in hypertrophic cardiomyopathy
-
Spirito P, Bellone P, Harris KM, Bernabo P, Bruzzi P, Maron BJ. Magnitude of left ventricular hypertrophy and risk of sudden death in hypertrophic cardiomyopathy. N Engl J Med 2000;342(24):1778-85.
-
(2000)
N Engl J Med
, vol.342
, Issue.24
, pp. 1778-1785
-
-
Spirito, P.1
Bellone, P.2
Harris, K.M.3
Bernabo, P.4
Bruzzi, P.5
Maron, B.J.6
-
35
-
-
0035835456
-
Relation between severity of left-ventricular hypertrophy and prognosis in patients with hypertrophic cardiomyopathy
-
Elliott PM, Gimeno Blanes JR, Mahon NG, Poloniecki JD, McKenna WJ. Relation between severity of left-ventricular hypertrophy and prognosis in patients with hypertrophic cardiomyopathy. Lancet 2001;357(9254):420-4.
-
(2001)
Lancet
, vol.357
, Issue.9254
, pp. 420-424
-
-
Elliott, P.M.1
Gimeno Blanes, J.R.2
Mahon, N.G.3
Poloniecki, J.D.4
McKenna, W.J.5
-
36
-
-
0037454155
-
On predictors of sudden cardiac death in hypertrophic cardiomyopathy
-
Marian AJ. On predictors of sudden cardiac death in hypertrophic cardiomyopathy. J Am Coll Cardiol 2003;41(6):994-6.
-
(2003)
J Am Coll Cardiol
, vol.41
, Issue.6
, pp. 994-996
-
-
Marian, A.J.1
-
37
-
-
0042377368
-
Non-sustained ventricular tachycardia in hypertrophic cardiomyopathy: An independent marker of sudden death risk in young patients
-
Monserrat L, Elliott PM, Gimeno JR, Sharma S, Penas-Lado M, McKenna WJ. Non-sustained ventricular tachycardia in hypertrophic cardiomyopathy: an independent marker of sudden death risk in young patients. J Am Coll Cardiol 2003; 42(5):873-9.
-
(2003)
J Am Coll Cardiol
, vol.42
, Issue.5
, pp. 873-879
-
-
Monserrat, L.1
Elliott, P.M.2
Gimeno, J.R.3
Sharma, S.4
Penas-Lado, M.5
McKenna, W.J.6
-
38
-
-
1942436225
-
Assessing the risk of sudden cardiac death in a patient with hypertrophic cardiomyopathy
-
Frenneaux MP. Assessing the risk of sudden cardiac death in a patient with hypertrophic cardiomyopathy. Heart 2004; 90(5):570-5.
-
(2004)
Heart
, vol.90
, Issue.5
, pp. 570-575
-
-
Frenneaux, M.P.1
-
39
-
-
0037192339
-
Sarcomere protein gene mutations in hypertrophic cardiomyopathy of the elderly
-
Niimura H, Patton KK, McKenna WJ, Soults J, Maron BJ, Seidman JG, Seidman CE. Sarcomere protein gene mutations in hypertrophic cardiomyopathy of the elderly. Circulation 2002;105(4):446-51.
-
(2002)
Circulation
, vol.105
, Issue.4
, pp. 446-451
-
-
Niimura, H.1
Patton, K.K.2
McKenna, W.J.3
Soults, J.4
Maron, B.J.5
Seidman, J.G.6
Seidman, C.E.7
-
40
-
-
0026573969
-
Characteristics and prognostic implications of myosin missense mutations in familial hypertrophic cardiomyopathy
-
Watkins H, Rosenzweig A, Hwang DS, Levi T, McKenna W, Seidman CE, Seidman JG. Characteristics and prognostic implications of myosin missense mutations in familial hypertrophic cardiomyopathy. N Engl J Med 1992;326(17):1108-14.
-
(1992)
N Engl J Med
, vol.326
, Issue.17
, pp. 1108-1114
-
-
Watkins, H.1
Rosenzweig, A.2
Hwang, D.S.3
Levi, T.4
McKenna, W.5
Seidman, C.E.6
Seidman, J.G.7
-
41
-
-
0028844204
-
Mutations in the cardiac myosin binding protein-C gene on chromosome 11 cause familial hypertrophic cardiomyopathy
-
Watkins H, Conner D, Thierfelder L, Jarcho JA, MacRae C, McKenna WJ, et al. Mutations in the cardiac myosin binding protein-C gene on chromosome 11 cause familial hypertrophic cardiomyopathy. Nat Genet 1995;11(4):434-7.
-
(1995)
Nat Genet
, vol.11
, Issue.4
, pp. 434-437
-
-
Watkins, H.1
Conner, D.2
Thierfelder, L.3
Jarcho, J.A.4
MacRae, C.5
McKenna, W.J.6
-
42
-
-
0028178083
-
Alpha-tropomyosin and cardiac troponin T mutations cause familial hypertrophic cardiomyopathy: A disease of the sarcomere
-
Thierfelder L, Watkins H, MacRae C, Lamas R, McKenna W, Vosberg HP, et al. Alpha-tropomyosin and cardiac troponin T mutations cause familial hypertrophic cardiomyopathy: a disease of the sarcomere. Cell 1994;77(5):701-12.
-
(1994)
Cell
, vol.77
, Issue.5
, pp. 701-712
-
-
Thierfelder, L.1
Watkins, H.2
MacRae, C.3
Lamas, R.4
McKenna, W.5
Vosberg, H.P.6
-
43
-
-
0033799445
-
Inherited and de novo mutations in the cardiac actin gene cause hypertrophic cardiomyopathy
-
Olson TM, Doan TP, Kishimoto NY, Whitby FG, Ackerman MJ, Fananapazir L. Inherited and de novo mutations in the cardiac actin gene cause hypertrophic cardiomyopathy. J Mol Cell Cardiol 2000;32(9):1687-94.
-
(2000)
J Mol Cell Cardiol
, vol.32
, Issue.9
, pp. 1687-1694
-
-
Olson, T.M.1
Doan, T.P.2
Kishimoto, N.Y.3
Whitby, F.G.4
Ackerman, M.J.5
Fananapazir, L.6
-
44
-
-
10644283181
-
Frequency and clinical expression of cardiac troponin I mutations in 748 consecutive families with hypertrophic cardiomyopathy
-
Mogensen J, Murphy RT, Kubo T, Bahl A, Moon JC, Klausen IC, et al. Frequency and clinical expression of cardiac troponin I mutations in 748 consecutive families with hypertrophic cardiomyopathy. J Am Coll Cardiol 2004;44(12): 2315-25.
-
(2004)
J Am Coll Cardiol
, vol.44
, Issue.12
, pp. 2315-2325
-
-
Mogensen, J.1
Murphy, R.T.2
Kubo, T.3
Bahl, A.4
Moon, J.C.5
Klausen, I.C.6
-
45
-
-
0028902929
-
Mutations in the genes for cardiac troponin T and alpha-tropomyosin in hypertrophic cardiomyopathy
-
Watkins H, McKenna WJ, Thierfelder L, Suk HJ, Anan R, O'Donoghue A, et al. Mutations in the genes for cardiac troponin T and alpha-tropomyosin in hypertrophic cardiomyopathy. N Engl J Med 1995;332(16):1058-64.
-
(1995)
N Engl J Med
, vol.332
, Issue.16
, pp. 1058-1064
-
-
Watkins, H.1
McKenna, W.J.2
Thierfelder, L.3
Suk, H.J.4
Anan, R.5
O'Donoghue, A.6
-
46
-
-
19944434362
-
Glycogen storage diseases presenting as hypertrophic cardiomyopathy
-
Arad M, Maron BJ, Gorham JM, Johnson WH Jr, Saul JP, Perez-Atayde AR, et al. Glycogen storage diseases presenting as hypertrophic cardiomyopathy. N Engl J Med 2005;352(4): 362-72.
-
(2005)
N Engl J Med
, vol.352
, Issue.4
, pp. 362-372
-
-
Arad, M.1
Maron, B.J.2
Gorham, J.M.3
Johnson Jr, W.H.4
Saul, J.P.5
Perez-Atayde, A.R.6
-
47
-
-
4544344055
-
Prevalence of Fabry disease in female patients with late-onset hypertrophic cardiomyopathy
-
Chimenti C, Pieroni M, Morgante E, Antuzzi D, Russo A, Russo MA, et al. Prevalence of Fabry disease in female patients with late-onset hypertrophic cardiomyopathy. Circulation 2004;110(9):1047-53.
-
(2004)
Circulation
, vol.110
, Issue.9
, pp. 1047-1053
-
-
Chimenti, C.1
Pieroni, M.2
Morgante, E.3
Antuzzi, D.4
Russo, A.5
Russo, M.A.6
-
48
-
-
0037177166
-
Prevalence of Anderson-Fabry disease in male patients with late onset hypertrophic cardiomyopathy
-
Sachdev B, Takenaka T, Teraguchi H, Tei C, Lee P, McKenna WJ, Elliott PM. Prevalence of Anderson-Fabry disease in male patients with late onset hypertrophic cardiomyopathy. Circulation 2002;105(12):1407-11.
-
(2002)
Circulation
, vol.105
, Issue.12
, pp. 1407-1411
-
-
Sachdev, B.1
Takenaka, T.2
Teraguchi, H.3
Tei, C.4
Lee, P.5
McKenna, W.J.6
Elliott, P.M.7
-
49
-
-
0035910109
-
Novel PRKAG2 mutation responsible for the genetic syndrome of ventricular preexcitation and conduction system disease with childhood onset and absence of cardiac hypertrophy
-
Gollob MH, Seger JJ, Gollob TN, Tapscott T, Gonzales O, Bachinski L, Roberts R. Novel PRKAG2 mutation responsible for the genetic syndrome of ventricular preexcitation and conduction system disease with childhood onset and absence of cardiac hypertrophy. Circulation 2001;104(25):3030-3.
-
(2001)
Circulation
, vol.104
, Issue.25
, pp. 3030-3033
-
-
Gollob, M.H.1
Seger, J.J.2
Gollob, T.N.3
Tapscott, T.4
Gonzales, O.5
Bachinski, L.6
Roberts, R.7
-
50
-
-
0035859215
-
Identification of a gene responsible for familial Wolff-Parkinson-White syndrome
-
Gollob MH, Green MS, Tang AS, Gollob T, Karibe A, Ali Hassan AS, et al. Identification of a gene responsible for familial Wolff-Parkinson-White syndrome. N Engl J Med 2001; 344(24):1823-31.
-
(2001)
N Engl J Med
, vol.344
, Issue.24
, pp. 1823-1831
-
-
Gollob, M.H.1
Green, M.S.2
Tang, A.S.3
Gollob, T.4
Karibe, A.5
Ali Hassan, A.S.6
-
51
-
-
0035872209
-
Mutations in the gamma(2) subunit of AMPactivated protein kinase cause familial hypertrophic cardiomyopathy: Evidence for the central role of energy compromise in disease pathogenesis
-
Blair E, Redwood C, Ashrafian H, Oliveira M, Broxholme J, Kerr B, et al. Mutations in the gamma(2) subunit of AMPactivated protein kinase cause familial hypertrophic cardiomyopathy: evidence for the central role of energy compromise in disease pathogenesis. Hum Mol Genet 2001;10(11):1215-20.
-
(2001)
Hum Mol Genet
, vol.10
, Issue.11
, pp. 1215-1220
-
-
Blair, E.1
Redwood, C.2
Ashrafian, H.3
Oliveira, M.4
Broxholme, J.5
Kerr, B.6
-
52
-
-
0036100436
-
Modifier genes for hypertrophic cardiomyopathy
-
Marian AJ. Modifier genes for hypertrophic cardiomyopathy. Curr Opin Cardiol 2002;17(3):242-52.
-
(2002)
Curr Opin Cardiol
, vol.17
, Issue.3
, pp. 242-252
-
-
Marian, A.J.1
-
53
-
-
0034502439
-
Variants of trophic factors and expression of cardiac hypertrophy in patients with hypertrophic cardiomyopathy
-
Patel R, Lim DS, Reddy D, Nagueh SF, Lutucuta S, Sole MJ, et al. Variants of trophic factors and expression of cardiac hypertrophy in patients with hypertrophic cardiomyopathy. J Mol Cell Cardiol 2000;32(12):2369-77.
-
(2000)
J Mol Cell Cardiol
, vol.32
, Issue.12
, pp. 2369-2377
-
-
Patel, R.1
Lim, D.S.2
Reddy, D.3
Nagueh, S.F.4
Lutucuta, S.5
Sole, M.J.6
-
54
-
-
0031301663
-
Role of candidate modifier genes on the phenotypic expression of hypertrophy in patients with hypertrophic cardiomyopathy
-
Brugada R, Kelsey W, Lechin M, Zhao G, Yu QT, Zoghbi W, et al. Role of candidate modifier genes on the phenotypic expression of hypertrophy in patients with hypertrophic cardiomyopathy. J Investig Med 1997;45(9):542-51.
-
(1997)
J Investig Med
, vol.45
, Issue.9
, pp. 542-551
-
-
Brugada, R.1
Kelsey, W.2
Lechin, M.3
Zhao, G.4
Yu, Q.T.5
Zoghbi, W.6
-
55
-
-
49449088978
-
Identifying modifier loci in existing genome scan data
-
Daw EW, Lu Y, Marian AJ, Shete S. Identifying modifier loci in existing genome scan data. Ann Hum Genet 2008;72(Pt 5):670-5.
-
(2008)
Ann Hum Genet
, vol.72
, Issue.PART 5
, pp. 670-675
-
-
Daw, E.W.1
Lu, Y.2
Marian, A.J.3
Shete, S.4
-
56
-
-
34848876400
-
Genome-wide mapping of modifier chromosomal loci for human hypertrophic cardiomyopathy
-
Daw EW, Chen SN, Czernuszewicz G, Lombardi R, Lu Y, Ma J, et al. Genome-wide mapping of modifier chromosomal loci for human hypertrophic cardiomyopathy. Hum Mol Genet 2007;16(20):2463-71.
-
(2007)
Hum Mol Genet
, vol.16
, Issue.20
, pp. 2463-2471
-
-
Daw, E.W.1
Chen, S.N.2
Czernuszewicz, G.3
Lombardi, R.4
Lu, Y.5
Ma, J.6
-
57
-
-
0037070514
-
Hypertrophic cardiomyopathy: A systematic review
-
Maron BJ. Hypertrophic cardiomyopathy: a systematic review. JAMA 2002;287(10):1308-20.
-
(2002)
JAMA
, vol.287
, Issue.10
, pp. 1308-1320
-
-
Maron, B.J.1
-
58
-
-
0033571197
-
A cohort study of childhood hypertrophic cardiomyopathy: Improved survival following high-dose beta-adrenoceptor antagonist treatment
-
Ostman-Smith I, Wettrell G, Riesenfeld T. A cohort study of childhood hypertrophic cardiomyopathy: improved survival following high-dose beta-adrenoceptor antagonist treatment. J Am Coll Cardiol 1999;34(6):1813-22.
-
(1999)
J Am Coll Cardiol
, vol.34
, Issue.6
, pp. 1813-1822
-
-
Ostman-Smith, I.1
Wettrell, G.2
Riesenfeld, T.3
-
59
-
-
17144401887
-
Multicenter study of the efficacy and safety of disopyramide in obstructive hypertrophic cardiomyopathy
-
Sherrid MV, Barac I, McKenna WJ, Elliott PM, Dickie S, Chojnowska L, et al. Multicenter study of the efficacy and safety of disopyramide in obstructive hypertrophic cardiomyopathy. J Am Coll Cardiol 2005;45(8):1251-8.
-
(2005)
J Am Coll Cardiol
, vol.45
, Issue.8
, pp. 1251-1258
-
-
Sherrid, M.V.1
Barac, I.2
McKenna, W.J.3
Elliott, P.M.4
Dickie, S.5
Chojnowska, L.6
-
60
-
-
12144288228
-
Aldosterone, through novel signaling proteins, is a fundamental molecular bridge between the genetic defect and the cardiac phenotype of hypertrophic cardiomyopathy
-
Tsybouleva N, Zhang L, Chen S, Patel R, Lutucuta S, Nemoto S, et al. Aldosterone, through novel signaling proteins, is a fundamental molecular bridge between the genetic defect and the cardiac phenotype of hypertrophic cardiomyopathy. Circulation 2004;109(10):1284-91.
-
(2004)
Circulation
, vol.109
, Issue.10
, pp. 1284-1291
-
-
Tsybouleva, N.1
Zhang, L.2
Chen, S.3
Patel, R.4
Lutucuta, S.5
Nemoto, S.6
-
61
-
-
28044470767
-
Effect of Losartan on left ventricular diastolic function in patients with nonobstructive hypertrophic cardiomyopathy
-
Araujo AQ, Arteaga E, Ianni BM, Buck PC, Rabello R, Mady C. Effect of Losartan on left ventricular diastolic function in patients with nonobstructive hypertrophic cardiomyopathy. Am J Cardiol 2005;96(11):1563-7.
-
(2005)
Am J Cardiol
, vol.96
, Issue.11
, pp. 1563-1567
-
-
Araujo, A.Q.1
Arteaga, E.2
Ianni, B.M.3
Buck, P.C.4
Rabello, R.5
Mady, C.6
-
62
-
-
0021346026
-
Patterns of inheritance in hypertrophic cardiomyopathy: Assessment by M-mode and two-dimensional echocardiography
-
Maron BJ, Nichols PF 3rd, Pickle LW, Wesley YE, Mulvihill JJ. Patterns of inheritance in hypertrophic cardiomyopathy: assessment by M-mode and two-dimensional echocardiography. Am J Cardiol 1984;53(8):1087-94.
-
(1984)
Am J Cardiol
, vol.53
, Issue.8
, pp. 1087-1094
-
-
Maron, B.J.1
Nichols 3rd, P.F.2
Pickle, L.W.3
Wesley, Y.E.4
Mulvihill, J.J.5
-
63
-
-
0023258399
-
Inheritance of hypertrophic cardiomyopathy: A cross sectional and M mode echocardiographic study of 50 families
-
Greaves SC, Roche AH, Neutze JM, Whitlock RM, Veale AM. Inheritance of hypertrophic cardiomyopathy: a cross sectional and M mode echocardiographic study of 50 families. Br Heart J 1987;58(3):259-66.
-
(1987)
Br Heart J
, vol.58
, Issue.3
, pp. 259-266
-
-
Greaves, S.C.1
Roche, A.H.2
Neutze, J.M.3
Whitlock, R.M.4
Veale, A.M.5
-
64
-
-
0026319459
-
The frequency of familial dilated cardiomyopathy in a series of patients with idiopathic dilated cardiomyopathy
-
Michels VV, Moll PP, Miller FA, Tajik AJ, Chu JS, Driscoll DJ, et al. The frequency of familial dilated cardiomyopathy in a series of patients with idiopathic dilated cardiomyopathy. N Engl J Med 1992;326(2):77-82.
-
(1992)
N Engl J Med
, vol.326
, Issue.2
, pp. 77-82
-
-
Michels, V.V.1
Moll, P.P.2
Miller, F.A.3
Tajik, A.J.4
Chu, J.S.5
Driscoll, D.J.6
-
65
-
-
0037173015
-
Assessment of diastolic function with Doppler tissue imaging to predict genotype in preclinical hypertrophic cardiomyopathy
-
Ho CY, Sweitzer NK, McDonough B, Maron BJ, Casey SA, Seidman JG, et al. Assessment of diastolic function with Doppler tissue imaging to predict genotype in preclinical hypertrophic cardiomyopathy. Circulation 2002;105(25):2992-7.
-
(2002)
Circulation
, vol.105
, Issue.25
, pp. 2992-2997
-
-
Ho, C.Y.1
Sweitzer, N.K.2
McDonough, B.3
Maron, B.J.4
Casey, S.A.5
Seidman, J.G.6
-
66
-
-
33845338760
-
Structural abnormalities of the inferoseptal left ventricular wall detected by cardiac magnetic resonance imaging in carriers of hypertrophic cardiomyopathy mutations
-
Germans T, Wilde AA, Dijkmans PA, Chai W, Kamp O, Pinto YM, van Rossum AC. Structural abnormalities of the inferoseptal left ventricular wall detected by cardiac magnetic resonance imaging in carriers of hypertrophic cardiomyopathy mutations. J Am Coll Cardiol 2006;48(12):2518-23.
-
(2006)
J Am Coll Cardiol
, vol.48
, Issue.12
, pp. 2518-2523
-
-
Germans, T.1
Wilde, A.A.2
Dijkmans, P.A.3
Chai, W.4
Kamp, O.5
Pinto, Y.M.6
van Rossum, A.C.7
-
67
-
-
0037138579
-
Long-term outcome in patients with apical hypertrophic cardiomyopathy
-
Eriksson MJ, Sonnenberg B, Woo A, Rakowski P, Parker TG, Wigle ED, Rakowski H. Long-term outcome in patients with apical hypertrophic cardiomyopathy. J Am Coll Cardiol 2002;39(4):638-45.
-
(2002)
J Am Coll Cardiol
, vol.39
, Issue.4
, pp. 638-645
-
-
Eriksson, M.J.1
Sonnenberg, B.2
Woo, A.3
Rakowski, P.4
Parker, T.G.5
Wigle, E.D.6
Rakowski, H.7
-
68
-
-
0028818347
-
Hypertrophic cardiomyopathy in Tuscany: Clinical course and outcome in an unselected regional population
-
Cecchi F, Olivotto I, Montereggi A, Santoro G, Dolara A, Maron BJ. Hypertrophic cardiomyopathy in Tuscany: clinical course and outcome in an unselected regional population. J Am Coll Cardiol 1995;26(6):1529-36.
-
(1995)
J Am Coll Cardiol
, vol.26
, Issue.6
, pp. 1529-1536
-
-
Cecchi, F.1
Olivotto, I.2
Montereggi, A.3
Santoro, G.4
Dolara, A.5
Maron, B.J.6
-
69
-
-
0024522202
-
Clinical course and prognosis of hypertrophic cardiomyopathy in an outpatient population
-
Spirito P, Chiarella F, Carratino L, Berisso MZ, Bellotti P, Vecchio C. Clinical course and prognosis of hypertrophic cardiomyopathy in an outpatient population. N Engl J Med 1989;320(12):749-55.
-
(1989)
N Engl J Med
, vol.320
, Issue.12
, pp. 749-755
-
-
Spirito, P.1
Chiarella, F.2
Carratino, L.3
Berisso, M.Z.4
Bellotti, P.5
Vecchio, C.6
-
70
-
-
0141630291
-
Efficacy of implantable cardioverter defibrillator therapy for primary and secondary prevention of sudden cardiac death in hypertrophic cardiomyopathy
-
Begley DA, Mohiddin SA, Tripodi D, Winkler JB, Fananapazir L. Efficacy of implantable cardioverter defibrillator therapy for primary and secondary prevention of sudden cardiac death in hypertrophic cardiomyopathy. Pacing Clin Electrophysiol 2003;26(9):1887-96.
-
(2003)
Pacing Clin Electrophysiol
, vol.26
, Issue.9
, pp. 1887-1896
-
-
Begley, D.A.1
Mohiddin, S.A.2
Tripodi, D.3
Winkler, J.B.4
Fananapazir, L.5
-
71
-
-
19444381099
-
Significance and relation between magnitude of left ventricular hypertrophy and heart failure symptoms in hypertrophic cardiomyopathy
-
Maron MS, Zenovich AG, Casey SA, Link MS, Udelson JE, Aeppli DM, Maron BJ. Significance and relation between magnitude of left ventricular hypertrophy and heart failure symptoms in hypertrophic cardiomyopathy. Am J Cardiol 2005;95(11):1329-33.
-
(2005)
Am J Cardiol
, vol.95
, Issue.11
, pp. 1329-1333
-
-
Maron, M.S.1
Zenovich, A.G.2
Casey, S.A.3
Link, M.S.4
Udelson, J.E.5
Aeppli, D.M.6
Maron, B.J.7
-
72
-
-
0037438614
-
Maximum left ventricular thickness and risk of sudden death in patients with hypertrophic cardiomyopathy
-
Olivotto I, Gistri R, Petrone P, Pedemonte E, Vargiu D, Cecchi F. Maximum left ventricular thickness and risk of sudden death in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 2003;41(2):315-21.
-
(2003)
J Am Coll Cardiol
, vol.41
, Issue.2
, pp. 315-321
-
-
Olivotto, I.1
Gistri, R.2
Petrone, P.3
Pedemonte, E.4
Vargiu, D.5
Cecchi, F.6
-
73
-
-
0031922826
-
A high risk phenotype of hypertrophic cardiomyopathy associated with a compound genotype of two mutated beta-myosin heavy chain genes
-
Jeschke B, Uhl K, Weist B, Schroder D, Meitinger T, Dohlemann C, Vosberg HP. A high risk phenotype of hypertrophic cardiomyopathy associated with a compound genotype of two mutated beta-myosin heavy chain genes. Hum Genet 1998; 102(3):299-304.
-
(1998)
Hum Genet
, vol.102
, Issue.3
, pp. 299-304
-
-
Jeschke, B.1
Uhl, K.2
Weist, B.3
Schroder, D.4
Meitinger, T.5
Dohlemann, C.6
Vosberg, H.P.7
-
74
-
-
0027954269
-
Prognostic implications of novel beta cardiac myosin heavy chain gene mutations that cause familial hypertrophic cardiomyopathy
-
Anan R, Greve G, Thierfelder L, Watkins H, McKenna WJ, Solomon S, et al. Prognostic implications of novel beta cardiac myosin heavy chain gene mutations that cause familial hypertrophic cardiomyopathy. J Clin Invest 1994;93(1):280-5.
-
(1994)
J Clin Invest
, vol.93
, Issue.1
, pp. 280-285
-
-
Anan, R.1
Greve, G.2
Thierfelder, L.3
Watkins, H.4
McKenna, W.J.5
Solomon, S.6
-
75
-
-
0031114657
-
Prognostic significance of beta-myosin heavy chain mutations is reflective of their hypertrophic expressivity in patients with hypertrophic cardiomyopathy
-
Abchee A, Marian AJ. Prognostic significance of beta-myosin heavy chain mutations is reflective of their hypertrophic expressivity in patients with hypertrophic cardiomyopathy. J Investig Med 1997;45(4):191-6.
-
(1997)
J Investig Med
, vol.45
, Issue.4
, pp. 191-196
-
-
Abchee, A.1
Marian, A.J.2
-
76
-
-
0033005768
-
Double heterozygosity for mutations in the beta-myosin heavy chain and in the cardiac myosin binding protein C genes in a family with hypertrophic cardiomyopathy
-
Richard P, Isnard R, Carrier L, Dubourg O, Donatien Y, Mathieu B, et al. Double heterozygosity for mutations in the beta-myosin heavy chain and in the cardiac myosin binding protein C genes in a family with hypertrophic cardiomyopathy. J Med Genet 1999;36(7):542-5.
-
(1999)
J Med Genet
, vol.36
, Issue.7
, pp. 542-545
-
-
Richard, P.1
Isnard, R.2
Carrier, L.3
Dubourg, O.4
Donatien, Y.5
Mathieu, B.6
-
77
-
-
15944371567
-
The prognostic importance of left ventricular outflow obstruction in hypertrophic cardiomyopathy varies in relation to the severity of symptoms
-
Autore C, Bernabo P, Barilla CS, Bruzzi P, Spirito P. The prognostic importance of left ventricular outflow obstruction in hypertrophic cardiomyopathy varies in relation to the severity of symptoms. J Am Coll Cardiol 2005;45(7):1076-80.
-
(2005)
J Am Coll Cardiol
, vol.45
, Issue.7
, pp. 1076-1080
-
-
Autore, C.1
Bernabo, P.2
Barilla, C.S.3
Bruzzi, P.4
Spirito, P.5
-
78
-
-
8344290546
-
The case for surgery in obstructive hypertrophic cardiomyopathy
-
Maron BJ, Dearani JA, Ommen SR, Maron MS, Schaff HV, Gersh BJ, Nishimura RA. The case for surgery in obstructive hypertrophic cardiomyopathy. J Am Coll Cardiol 2004; 44(10):2044-53.
-
(2004)
J Am Coll Cardiol
, vol.44
, Issue.10
, pp. 2044-2053
-
-
Maron, B.J.1
Dearani, J.A.2
Ommen, S.R.3
Maron, M.S.4
Schaff, H.V.5
Gersh, B.J.6
Nishimura, R.A.7
-
79
-
-
34948837107
-
Surgical septal myectomy decreases the risk for appropriate implantable cardioverter defibrillator discharge in obstructive hypertrophic cardiomyopathy
-
McLeod CJ, Ommen SR, Ackerman MJ, Weivoda PL, Shen WK, Dearani JA, et al. Surgical septal myectomy decreases the risk for appropriate implantable cardioverter defibrillator discharge in obstructive hypertrophic cardiomyopathy. Eur Heart J 2007;28(21):2583-8.
-
(2007)
Eur Heart J
, vol.28
, Issue.21
, pp. 2583-2588
-
-
McLeod, C.J.1
Ommen, S.R.2
Ackerman, M.J.3
Weivoda, P.L.4
Shen, W.K.5
Dearani, J.A.6
-
80
-
-
8344263111
-
Clinical and echocardiographic determinants of long-term survival after surgical myectomy in obstructive hypertrophic cardiomyopathy
-
Woo A, Williams WG, Choi R, Wigle ED, Rozenblyum E, Fedwick K, et al. Clinical and echocardiographic determinants of long-term survival after surgical myectomy in obstructive hypertrophic cardiomyopathy. Circulation 2005;111(16): 2033-41.
-
(2005)
Circulation
, vol.111
, Issue.16
, pp. 2033-2041
-
-
Woo, A.1
Williams, W.G.2
Choi, R.3
Wigle, E.D.4
Rozenblyum, E.5
Fedwick, K.6
-
81
-
-
0036800523
-
Septal myotomy-myectomy and transcoronary septal alcohol ablation in hypertrophic obstructive cardiomyopathy. A comparison of clinical, haemodynamic and exercise outcomes
-
Firoozi S, Elliott PM, Sharma S, Murday A, Brecker SJ, Hamid MS, et al. Septal myotomy-myectomy and transcoronary septal alcohol ablation in hypertrophic obstructive cardiomyopathy. A comparison of clinical, haemodynamic and exercise outcomes. Eur Heart J 2002;23(20):1617-24.
-
(2002)
Eur Heart J
, vol.23
, Issue.20
, pp. 1617-1624
-
-
Firoozi, S.1
Elliott, P.M.2
Sharma, S.3
Murday, A.4
Brecker, S.J.5
Hamid, M.S.6
-
82
-
-
52649134379
-
Left ventricular outf low tract obstruction in hypertrophic cardiomyopathy: Past, present and future
-
Ommen SR, Shah PM, Tajik AJ. Left ventricular outf low tract obstruction in hypertrophic cardiomyopathy: past, present and future. Heart 2008;94(10):1276-81.
-
(2008)
Heart
, vol.94
, Issue.10
, pp. 1276-1281
-
-
Ommen, S.R.1
Shah, P.M.2
Tajik, A.J.3
-
83
-
-
15944418799
-
Long-term effects of surgical septal myectomy on survival in patients with obstructive hypertrophic cardiomyopathy
-
Ommen SR, Maron BJ, Olivotto I, Maron MS, Cecchi F, Betocchi S, et al. Long-term effects of surgical septal myectomy on survival in patients with obstructive hypertrophic cardiomyopathy. J Am Coll Cardiol 2005;46(3):470-6.
-
(2005)
J Am Coll Cardiol
, vol.46
, Issue.3
, pp. 470-476
-
-
Ommen, S.R.1
Maron, B.J.2
Olivotto, I.3
Maron, M.S.4
Cecchi, F.5
Betocchi, S.6
-
84
-
-
4644237499
-
Monomorphic ventricular tachycardia: A late complication of percutaneous alcohol septal ablation for hypertrophic cardiomyopathy
-
McGregor JB, Rahman A, Rosanio S, Ware D, Birnbaum Y, Saeed M. Monomorphic ventricular tachycardia: a late complication of percutaneous alcohol septal ablation for hypertrophic cardiomyopathy. Am J Med Sci 2004;328(3):185-8.
-
(2004)
Am J Med Sci
, vol.328
, Issue.3
, pp. 185-188
-
-
McGregor, J.B.1
Rahman, A.2
Rosanio, S.3
Ware, D.4
Birnbaum, Y.5
Saeed, M.6
-
85
-
-
9344234401
-
Septal myectomy results in regression of left ventricular hypertrophy in patients with hypertrophic obstructive cardiomyopathy
-
Deb SJ, Schaff HV, Dearani JA, Nishimura RA, Ommen SR. Septal myectomy results in regression of left ventricular hypertrophy in patients with hypertrophic obstructive cardiomyopathy. Ann Thorac Surg 2004;78(6):2118-22.
-
(2004)
Ann Thorac Surg
, vol.78
, Issue.6
, pp. 2118-2122
-
-
Deb, S.J.1
Schaff, H.V.2
Dearani, J.A.3
Nishimura, R.A.4
Ommen, S.R.5
-
86
-
-
47649096007
-
Catheter treatment for hypertrophic obstructive cardiomyopathy: For seniors only?
-
Sigwart U. Catheter treatment for hypertrophic obstructive cardiomyopathy: for seniors only? Circulation 2008;118(2): 107-8.
-
(2008)
Circulation
, vol.118
, Issue.2
, pp. 107-108
-
-
Sigwart, U.1
-
87
-
-
0035165382
-
Echocardiographic insights into the mechanisms of relief of left ventricular outflow tract obstruction after nonsurgical septal reduction therapy in patients with hypertrophic obstructive cardiomyopathy
-
Flores-Ramirez R, Lakkis NM, Middleton KJ, Killip D, Spencer WH 3rd, Nagueh SF. Echocardiographic insights into the mechanisms of relief of left ventricular outflow tract obstruction after nonsurgical septal reduction therapy in patients with hypertrophic obstructive cardiomyopathy. J Am Coll Cardiol 2001;37(1):208-14.
-
(2001)
J Am Coll Cardiol
, vol.37
, Issue.1
, pp. 208-214
-
-
Flores-Ramirez, R.1
Lakkis, N.M.2
Middleton, K.J.3
Killip, D.4
Spencer 3rd, W.H.5
Nagueh, S.F.6
-
88
-
-
33751426386
-
Left ventricular remodeling of hypertrophic cardiomyopathy: Longitudinal observation in rural community
-
Kitaoka H, Kubo T, Okawa M, Hitomi N, Furuno T, Doi YL. Left ventricular remodeling of hypertrophic cardiomyopathy: longitudinal observation in rural community. Circ J 2006;70 (12):1543-9.
-
(2006)
Circ J
, vol.70
, Issue.12
, pp. 1543-1549
-
-
Kitaoka, H.1
Kubo, T.2
Okawa, M.3
Hitomi, N.4
Furuno, T.5
Doi, Y.L.6
-
89
-
-
41549132685
-
Survival after transcoronary ablation of septal hypertrophy in hypertrophic obstructive cardiomyopathy (TASH): A 10 year experience
-
Kuhn H, Lawrenz T, Lieder F, Leuner C, Strunk-Mueller C, Obergassel L, et al. Survival after transcoronary ablation of septal hypertrophy in hypertrophic obstructive cardiomyopathy (TASH): a 10 year experience. Clin Res Cardiol 2008; 97(4):234-43.
-
(2008)
Clin Res Cardiol
, vol.97
, Issue.4
, pp. 234-243
-
-
Kuhn, H.1
Lawrenz, T.2
Lieder, F.3
Leuner, C.4
Strunk-Mueller, C.5
Obergassel, L.6
-
90
-
-
12144290279
-
Percutaneous transluminal septal reduction for hypertrophic obstructive cardiomyopathy: Report from an international pilot study
-
Buell HE, Stables RH, DeLong ER, Shuping KB, Killip DM, Lever HM, et al. Percutaneous transluminal septal reduction for hypertrophic obstructive cardiomyopathy: report from an international pilot study. J Med Syst 2002;26 (4):293-300.
-
(2002)
J Med Syst
, vol.26
, Issue.4
, pp. 293-300
-
-
Buell, H.E.1
Stables, R.H.2
DeLong, E.R.3
Shuping, K.B.4
Killip, D.M.5
Lever, H.M.6
-
91
-
-
0030997143
-
Nonsurgical septal reduction for hypertrophic obstructive cardiomyopathy: Outcome in the first series of patients
-
Knight C, Kurbaan AS, Seggewiss H, Henein M, Gunning M, Harrington D, et al. Nonsurgical septal reduction for hypertrophic obstructive cardiomyopathy: outcome in the first series of patients. Circulation 1997;95(8):2075-81.
-
(1997)
Circulation
, vol.95
, Issue.8
, pp. 2075-2081
-
-
Knight, C.1
Kurbaan, A.S.2
Seggewiss, H.3
Henein, M.4
Gunning, M.5
Harrington, D.6
-
92
-
-
0035890036
-
Comparison of ethanol septal reduction therapy with surgical myectomy for the treatment of hypertrophic obstructive cardiomyopathy
-
Nagueh SF, Ommen SR, Lakkis NM, Killip D, Zoghbi WA, Schaff HV, et al. Comparison of ethanol septal reduction therapy with surgical myectomy for the treatment of hypertrophic obstructive cardiomyopathy. J Am Coll Cardiol 2001; 38(6):1701-6.
-
(2001)
J Am Coll Cardiol
, vol.38
, Issue.6
, pp. 1701-1706
-
-
Nagueh, S.F.1
Ommen, S.R.2
Lakkis, N.M.3
Killip, D.4
Zoghbi, W.A.5
Schaff, H.V.6
-
93
-
-
1842789044
-
Permanent pacing for complete atrioventricular block after nonsurgical (alcohol) septal reduction in patients with obstructive hypertrophic cardiomyopathy
-
Reinhard W, Ten Cate FJ, Scholten M, De Laat LE, Vos J. Permanent pacing for complete atrioventricular block after nonsurgical (alcohol) septal reduction in patients with obstructive hypertrophic cardiomyopathy. Am J Cardiol 2004; 93(8):1064-6.
-
(2004)
Am J Cardiol
, vol.93
, Issue.8
, pp. 1064-1066
-
-
Reinhard, W.1
Ten Cate, F.J.2
Scholten, M.3
De Laat, L.E.4
Vos, J.5
-
94
-
-
33846542616
-
Predictors of complete heart block after alcohol septal ablation for hypertrophic cardiomyopathy and the timing of pacemaker implantation
-
El-Jack SS, Nasif M, Blake JW, Dixon SR, Grines CL, O'Neill WW. Predictors of complete heart block after alcohol septal ablation for hypertrophic cardiomyopathy and the timing of pacemaker implantation. J Interv Cardiol 2007;20(1):73-6.
-
(2007)
J Interv Cardiol
, vol.20
, Issue.1
, pp. 73-76
-
-
El-Jack, S.S.1
Nasif, M.2
Blake, J.W.3
Dixon, S.R.4
Grines, C.L.5
O'Neill, W.W.6
-
95
-
-
9144232514
-
Conduction system abnormalities in patients with obstructive hypertrophic cardiomyopathy following septal reduction interventions
-
Qin JX, Shiota T, Lever HM, Asher CR, Popovic ZB, Greenberg NL, et al. Conduction system abnormalities in patients with obstructive hypertrophic cardiomyopathy following septal reduction interventions. Am J Cardiol 2004;93(2):171-5.
-
(2004)
Am J Cardiol
, vol.93
, Issue.2
, pp. 171-175
-
-
Qin, J.X.1
Shiota, T.2
Lever, H.M.3
Asher, C.R.4
Popovic, Z.B.5
Greenberg, N.L.6
-
96
-
-
0031976561
-
Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: Acute results and 3-month follow-up in 25 patients
-
Seggewiss H, Gleichmann U, Faber L, Fassbender D, Schmidt HK, Strick S. Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: acute results and 3-month follow-up in 25 patients. J Am Coll Cardiol 1998;31(2):252-8.
-
(1998)
J Am Coll Cardiol
, vol.31
, Issue.2
, pp. 252-258
-
-
Seggewiss, H.1
Gleichmann, U.2
Faber, L.3
Fassbender, D.4
Schmidt, H.K.5
Strick, S.6
-
97
-
-
6944253543
-
Ventricular tachycardia complicating alcohol septal ablation
-
Boltwood CM Jr, Chien W, Ports T. Ventricular tachycardia complicating alcohol septal ablation. N Engl J Med 2004; 351(18):1914-5.
-
(2004)
N Engl J Med
, vol.351
, Issue.18
, pp. 1914-1915
-
-
Boltwood Jr, C.M.1
Chien, W.2
Ports, T.3
-
98
-
-
34250319816
-
Occurrence of de novo sustained monomorphic ventricular tachycardia induced after percutaneous transluminal alcohol septal myocardial ablation for hypertrophic obstructive cardiomyopathy
-
Hori Y, Ueda M, Nakayama T, Saegusa N, Uehara M, Lee K, et al. Occurrence of de novo sustained monomorphic ventricular tachycardia induced after percutaneous transluminal alcohol septal myocardial ablation for hypertrophic obstructive cardiomyopathy. Int J Cardiol 2007;119(3):403-7.
-
(2007)
Int J Cardiol
, vol.119
, Issue.3
, pp. 403-407
-
-
Hori, Y.1
Ueda, M.2
Nakayama, T.3
Saegusa, N.4
Uehara, M.5
Lee, K.6
-
99
-
-
14944368967
-
-
Fernandes VL, Nagueh SF, Wang W, Roberts R, Spencer WH 3rd. A prospective follow-up of alcohol septal ablation for symptomatic hypertrophic obstructive cardiomyopathy--the Baylor experience (1996-2002). Clin Cardiol 2005;28(3): 124-30.
-
Fernandes VL, Nagueh SF, Wang W, Roberts R, Spencer WH 3rd. A prospective follow-up of alcohol septal ablation for symptomatic hypertrophic obstructive cardiomyopathy--the Baylor experience (1996-2002). Clin Cardiol 2005;28(3): 124-30.
-
-
-
-
100
-
-
0033165555
-
Comparison of dual-chamber pacing versus septal myectomy for the treatment of patients with hypertrophic obstructive cardiomyopathy: A comparison of objective hemodynamic and exercise end points
-
Ommen SR, Nishimura RA, Squires RW, Schaff HV, Danielson GK, Tajik AJ. Comparison of dual-chamber pacing versus septal myectomy for the treatment of patients with hypertrophic obstructive cardiomyopathy: a comparison of objective hemodynamic and exercise end points. J Am Coll Cardiol 1999;34(1):191-6.
-
(1999)
J Am Coll Cardiol
, vol.34
, Issue.1
, pp. 191-196
-
-
Ommen, S.R.1
Nishimura, R.A.2
Squires, R.W.3
Schaff, H.V.4
Danielson, G.K.5
Tajik, A.J.6
-
101
-
-
0033536029
-
Assessment of permanent dualchamber pacing as a treatment for drug-refractory symptomatic patients with obstructive hypertrophic cardiomyopathy. A randomized, double-blind, crossover study (M-PATHY)
-
Maron BJ, Nishimura RA, McKenna WJ, Rakowski H, Josephson ME, Kieval RS. Assessment of permanent dualchamber pacing as a treatment for drug-refractory symptomatic patients with obstructive hypertrophic cardiomyopathy. A randomized, double-blind, crossover study (M-PATHY). Circulation 1999;99(22):2927-33.
-
(1999)
Circulation
, vol.99
, Issue.22
, pp. 2927-2933
-
-
Maron, B.J.1
Nishimura, R.A.2
McKenna, W.J.3
Rakowski, H.4
Josephson, M.E.5
Kieval, R.S.6
-
102
-
-
0028650316
-
Long-term results of dual-chamber (DDD) pacing in obstructive hypertrophic cardiomyopathy. Evidence for progressive symptomatic and hemodynamic improvement and reduction of left ventricular hypertrophy
-
Fananapazir L, Epstein ND, Curiel RV, Panza JA, Tripodi D, McAreavey D. Long-term results of dual-chamber (DDD) pacing in obstructive hypertrophic cardiomyopathy. Evidence for progressive symptomatic and hemodynamic improvement and reduction of left ventricular hypertrophy. Circulation 1994;90(6):2731-42.
-
(1994)
Circulation
, vol.90
, Issue.6
, pp. 2731-2742
-
-
Fananapazir, L.1
Epstein, N.D.2
Curiel, R.V.3
Panza, J.A.4
Tripodi, D.5
McAreavey, D.6
-
103
-
-
8544240103
-
Pacing in hypertrophic obstructive cardiomyopathy. A randomized crossover study. PIC Study Group
-
Kappenberger L, Linde C, Daubert C, McKenna W, Meisel E, Sadoul N, et al. Pacing in hypertrophic obstructive cardiomyopathy. A randomized crossover study. PIC Study Group. Eur Heart J 1997;18(8):1249-56.
-
(1997)
Eur Heart J
, vol.18
, Issue.8
, pp. 1249-1256
-
-
Kappenberger, L.1
Linde, C.2
Daubert, C.3
McKenna, W.4
Meisel, E.5
Sadoul, N.6
-
104
-
-
0142154966
-
Management of hypertrophic cardiomyopathy in children
-
Seggewiss H, Rigopoulos A. Management of hypertrophic cardiomyopathy in children. Paediatr Drugs 2003;5(10):663-72.
-
(2003)
Paediatr Drugs
, vol.5
, Issue.10
, pp. 663-672
-
-
Seggewiss, H.1
Rigopoulos, A.2
-
105
-
-
35648967680
-
HMG CoA reductase inhibition and left ventricular mass in hypertrophic cardiomyopathy: A randomized placebocontrolled pilot study
-
Bauersachs J, Stork S, Kung M, Waller C, Fidler F, Hoyer C, et al. HMG CoA reductase inhibition and left ventricular mass in hypertrophic cardiomyopathy: a randomized placebocontrolled pilot study. Eur J Clin Invest 2007;37(11):852-9.
-
(2007)
Eur J Clin Invest
, vol.37
, Issue.11
, pp. 852-859
-
-
Bauersachs, J.1
Stork, S.2
Kung, M.3
Waller, C.4
Fidler, F.5
Hoyer, C.6
-
106
-
-
37649017852
-
A new therapeutic strategy for hypertrophic nonobstructive cardiomyopathy in humans. A randomized and prospective study with an angiotensin II receptor blocker
-
Yamazaki T, Suzuki J, Shimamoto R, Tsuji T, Ohmoto-Sekine Y, Ohtomo K, Nagai R. A new therapeutic strategy for hypertrophic nonobstructive cardiomyopathy in humans. A randomized and prospective study with an angiotensin II receptor blocker. Int Heart J 2007;48(6):715-24.
-
(2007)
Int Heart J
, vol.48
, Issue.6
, pp. 715-724
-
-
Yamazaki, T.1
Suzuki, J.2
Shimamoto, R.3
Tsuji, T.4
Ohmoto-Sekine, Y.5
Ohtomo, K.6
Nagai, R.7
|